rs17431717

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000706469.1(SRSF9):​c.89+229C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.172 in 149,458 control chromosomes in the GnomAD database, including 2,437 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.17 ( 2437 hom., cov: 29)

Consequence

SRSF9
ENST00000706469.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.461

Publications

6 publications found
Variant links:
Genes affected
SRSF9 (HGNC:10791): (serine and arginine rich splicing factor 9) The protein encoded by this gene is a member of the serine/arginine (SR)-rich family of pre-mRNA splicing factors, which constitute part of the spliceosome. Each of these factors contains an RNA recognition motif (RRM) for binding RNA and an RS domain for binding other proteins. The RS domain is rich in serine and arginine residues and facilitates interaction between different SR splicing factors. In addition to being critical for mRNA splicing, the SR proteins have also been shown to be involved in mRNA export from the nucleus and in translation. Two pseudogenes, one on chromosome 15 and the other on chromosome 21, have been found for this gene. [provided by RefSeq, Sep 2010]
DYNLL1 (HGNC:15476): (dynein light chain LC8-type 1) Cytoplasmic dyneins are large enzyme complexes with a molecular mass of about 1,200 kD. They contain two force-producing heads formed primarily from dynein heavy chains, and stalks linking the heads to a basal domain, which contains a varying number of accessory intermediate chains. The complex is involved in intracellular transport and motility. The protein described in this record is a light chain and exists as part of this complex but also physically interacts with and inhibits the activity of neuronal nitric oxide synthase. Binding of this protein destabilizes the neuronal nitric oxide synthase dimer, a conformation necessary for activity, and it may regulate numerous biologic processes through its effects on nitric oxide synthase activity. Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.214 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DYNLL1NM_001037494.2 linkc.-7+4303G>A intron_variant Intron 1 of 2 NP_001032583.1 P63167Q6FGH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SRSF9ENST00000706469.1 linkc.89+229C>T intron_variant Intron 1 of 3 ENSP00000516402.1 A0A9L9PXJ8
DYNLL1ENST00000392509.6 linkc.-7+4303G>A intron_variant Intron 1 of 2 3 ENSP00000376297.2 P63167
DYNLL1ENST00000548342.5 linkc.-144+4303G>A intron_variant Intron 1 of 4 2 ENSP00000447907.1 P63167

Frequencies

GnomAD3 genomes
AF:
0.172
AC:
25646
AN:
149344
Hom.:
2438
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.218
Gnomad AMI
AF:
0.273
Gnomad AMR
AF:
0.120
Gnomad ASJ
AF:
0.362
Gnomad EAS
AF:
0.0376
Gnomad SAS
AF:
0.129
Gnomad FIN
AF:
0.120
Gnomad MID
AF:
0.229
Gnomad NFE
AF:
0.165
Gnomad OTH
AF:
0.180
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.172
AC:
25657
AN:
149458
Hom.:
2437
Cov.:
29
AF XY:
0.168
AC XY:
12254
AN XY:
72742
show subpopulations
African (AFR)
AF:
0.218
AC:
8793
AN:
40308
American (AMR)
AF:
0.120
AC:
1793
AN:
14994
Ashkenazi Jewish (ASJ)
AF:
0.362
AC:
1253
AN:
3466
East Asian (EAS)
AF:
0.0375
AC:
190
AN:
5062
South Asian (SAS)
AF:
0.128
AC:
610
AN:
4764
European-Finnish (FIN)
AF:
0.120
AC:
1187
AN:
9892
Middle Eastern (MID)
AF:
0.247
AC:
71
AN:
288
European-Non Finnish (NFE)
AF:
0.165
AC:
11142
AN:
67698
Other (OTH)
AF:
0.178
AC:
370
AN:
2078
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
997
1994
2991
3988
4985
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
272
544
816
1088
1360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.174
Hom.:
398
Bravo
AF:
0.175
Asia WGS
AF:
0.0880
AC:
307
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.77
CADD
Benign
13
DANN
Benign
0.75
PhyloP100
0.46
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17431717; hg19: chr12-120912210; API